Author

Xiao Xu

h-index 5 View on Semantic Scholar

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Longitudinal changes in type 2 and Aspergillus-specific biomarkers during omalizumab therapy for allergic bronchopulmonary aspergillosis: a 36-week study in Chinese patients

Allergic bronchopulmonary aspergillosis (ABPA) is a severe type 2 inflammatory airway disease caused by hypersensitivity to Aspergillus fumigatus . Although omalizumab has been used as an adjunctive therapy for ABPA, longitudinal changes in type 2 inflammatory and Aspergillus -specific biomarkers during treat...

Pei-Ze Liu, Meng-Wei Wu, Xu Li et al. · Frontiers in Immunology · 0 citations

Review Open access Jul 2026

Presenilin Deficiency Beyond Amyloid: Lessons from Presenilin 1/2 Conditional Double-Knockout Mice on Synaptic Failure, Calcium Dyshomeostasis, and Inflammation-Driven Alzheimer's disease.

It is concluded that PS integrate vesicular release machinery with trophic and inflammatory homeostasis; their loss initiates a multi-scale failure cascade that redefines early AD-related neurodegeneration beyond Aβ.

Guang Yang, Xiao Xu, Ying Xu · Brain Research Bulletin · 0 citations

Review Open access Jul 2026

TREM2 as a central immunometabolic hub in Alzheimer’s disease: linking microglial states, lipid stress, and disease-stage-specific intervention

The latest insights into TREM2 biology are synthesized, focusing on the role of TREM2 in microglial state transitions, lipid metabolism, and myelin turnover, and the pathophysiological relevance of soluble TREM2 (sTREM2) and AD-associated TREM2 variants are examined.

Guang Yang, Xiao Xu, Ying Xu · Frontiers in Immunology · 0 citations